Reference
Huang J, et al. Fluid retention-associated adverse events in patients treated with BCR::ABL1 inhibitors based on FDA Adverse Event Reporting System (FAERS): a retrospective pharmacovigilance study BMJ Open : 7 Aug 2023. Available from: URL: http://doi.org/10.1136/bmjopen-2022-071456
Rights and permissions
About this article
Cite this article
BCR-ABL TKI fluid retention-related AEs. Reactions Weekly 1969, 6 (2023). https://doi.org/10.1007/s40278-023-44472-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-44472-8